China Biologic Products Company Profile (NASDAQ:CBPO)

About China Biologic Products (NASDAQ:CBPO)

China Biologic Products logoChina Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories. The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC). It is developing Human fibrinogen, Immune Globulin Intravenous (Human), Human Antithrombin III (concentration), Human coagulation factor IX, Human Cytomegalovirus Immunoglobulin and Human Fibrin Sealant.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CBPO
  • CUSIP: N/A
  • Web: www.chinabiologic.com
Capitalization:
  • Market Cap: $2.67 billion
  • Outstanding Shares: 27,201,000
Average Prices:
  • 50 Day Moving Avg: $107.79
  • 200 Day Moving Avg: $108.72
  • 52 Week Range: $96.99 - $137.39
P/E:
  • Trailing P/E Ratio: 25.46
  • Foreward P/E Ratio: 16.78
  • P/E Growth: 1.60
Sales & Book Value:
  • Annual Revenue: $347.03 million
  • Price / Sales: 7.71
  • Book Value: $18.48 per share
  • Price / Book: 5.32
Profitability:
  • EBIDTA: $158.57 million
  • Net Margins: 31.28%
  • Return on Equity: 21.24%
  • Return on Assets: 18.39%
Debt:
  • Current Ratio: 5.14%
  • Quick Ratio: 3.16%
Misc:
  • Average Volume: 173,106 shs.
  • Beta: 1.74
  • Short Ratio: 7.9
 
Frequently Asked Questions for China Biologic Products (NASDAQ:CBPO)

What is China Biologic Products' stock symbol?

China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."

How were China Biologic Products' earnings last quarter?

China Biologic Products, Inc. (NASDAQ:CBPO) released its earnings results on Thursday, February, 23rd. The company reported $0.95 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.84 by $0.11. The firm earned $77.60 million during the quarter, compared to analysts' expectations of $76.61 million. China Biologic Products had a net margin of 31.28% and a return on equity of 21.24%. The business's quarterly revenue was up 13.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.74 EPS. View China Biologic Products' Earnings History.

When will China Biologic Products make its next earnings announcement?

China Biologic Products is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for China Biologic Products.

Where is China Biologic Products' stock going? Where will China Biologic Products' stock price be in 2017?

3 brokerages have issued 1-year price objectives for China Biologic Products' stock. Their predictions range from $135.00 to $140.00. On average, they expect China Biologic Products' share price to reach $137.50 in the next twelve months. View Analyst Ratings for China Biologic Products.

Are investors shorting China Biologic Products?

China Biologic Products saw a drop in short interest in the month of June. As of June 15th, there was short interest totalling 1,106,937 shares, a drop of 31.7% from the May 31st total of 1,621,375 shares. Based on an average daily trading volume, of 163,176 shares, the days-to-cover ratio is presently 6.8 days. Approximately 4.8% of the shares of the company are sold short.

Who are some of China Biologic Products' key competitors?

Who are China Biologic Products' key executives?

China Biologic Products' management team includes the folowing people:

  • David Gao, Chairman of the Board, President, Chief Executive Officer
  • Ming Yang CPA, Chief Financial Officer
  • Zhijing Liu, Corporate Vice President
  • Ming Yin, Senior Corporate Vice President
  • Gang Yang, Corporate Vice President, General Manager of Guizhou Taibang
  • David Hui Li, Director
  • Joseph J. Chow, Independent Director
  • Wenfang Liu, Independent Director
  • Yungang Lu, Independent Director
  • Xiaosheng Shao, Independent Director

Who owns China Biologic Products stock?

China Biologic Products' stock is owned by a number of of retail and institutional investors. Top institutional investors include Hermes Investment Management Ltd. (2.39%), Manning & Napier Advisors LLC (0.26%), Vontobel Asset Management Inc. (0.19%), Russell Investments Group Ltd. (0.17%) and Copper Rock Capital Partners LLC (0.09%). Company insiders that own China Biologic Products stock include David Gao, Ming Yang, Ming Yin, Sean Shao, Wenfang Liu, Wp X Biologics Llc, Zhijing Cbpo Liu and Zhijun Tong. View Institutional Ownership Trends for China Biologic Products.

Who sold China Biologic Products stock? Who is selling China Biologic Products stock?

China Biologic Products' stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Advisors LLC, Russell Investments Group Ltd., Copper Rock Capital Partners LLC and Vontobel Asset Management Inc.. Company insiders that have sold China Biologic Products stock in the last year include David Gao, Ming Yang, Sean Shao, Wenfang Liu and Zhijing Cbpo Liu. View Insider Buying and Selling for China Biologic Products.

Who bought China Biologic Products stock? Who is buying China Biologic Products stock?

China Biologic Products' stock was acquired by a variety of institutional investors in the last quarter, including Hermes Investment Management Ltd.. View Insider Buying and Selling for China Biologic Products.

How do I buy China Biologic Products stock?

Shares of China Biologic Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Biologic Products' stock price today?

One share of China Biologic Products stock can currently be purchased for approximately $98.32.


MarketBeat Community Rating for China Biologic Products (NASDAQ CBPO)
Community Ranking:  2.9 out of 5 ( )
Outperform Votes:  120 (Vote Outperform)
Underperform Votes:  86 (Vote Underperform)
Total Votes:  206
MarketBeat's community ratings are surveys of what our community members think about China Biologic Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $137.50 (39.85% upside)

Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/12/2017Jefferies Group LLCReiterated RatingBuy$140.00MediumView Rating Details
5/30/2017Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral -> NeutralMediumView Rating Details
3/3/2017Morgan StanleyReiterated RatingOverweight$135.00N/AView Rating Details
7/5/2016Credit Suisse GroupUpgradeNeutral -> OutperformN/AView Rating Details
1/7/2016Deutsche Bank AGBoost Price TargetBuy$149.00 -> $162.00N/AView Rating Details
(Data available from 7/25/2015 forward)

Earnings

Earnings History for China Biologic Products (NASDAQ:CBPO)
Earnings by Quarter for China Biologic Products (NASDAQ:CBPO)
Earnings History by Quarter for China Biologic Products (NASDAQ CBPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2017        
2/23/2017Q416$0.84$0.95$76.61 million$77.60 millionViewN/AView Earnings Details
11/2/2016Q316$1.05$1.22$88.46 million$86.50 millionViewN/AView Earnings Details
8/4/2016Q216$1.16$1.10$87.60 million$91.40 millionViewN/AView Earnings Details
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details
8/5/2015Q215$0.87$0.99$71.75 million$79.10 millionViewN/AView Earnings Details
5/6/2015Q1 15$0.84$0.87$70.35 millionViewN/AView Earnings Details
11/5/2014Q4 14$0.43$0.48$63.00 million$68.92 millionViewN/AView Earnings Details
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for China Biologic Products (NASDAQ:CBPO)
Current Year EPS Consensus Estimate: $4.98 EPS
Next Year EPS Consensus Estimate: $5.86 EPS

Dividends

Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for China Biologic Products (NASDAQ:CBPO)
Insider Ownership Percentage: 2.73%
Institutional Ownership Percentage: 74.25%
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Institutional Ownership by Quarter for China Biologic Products (NASDAQ:CBPO)
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2017Zhijing Cbpo LiuInsiderSell7,500$116.49$873,675.00View SEC Filing  
3/2/2017Sean ShaoDirectorSell20,000$100.78$2,015,600.00View SEC Filing  
3/1/2017David GaoCEOSell116,653$100.63$11,738,791.39View SEC Filing  
8/15/2016Ming YangCFOSell21,092$124.32$2,622,157.44View SEC Filing  
8/15/2016Wenfang LiuDirectorSell2,900$124.32$360,528.00View SEC Filing  
8/15/2016Zhijing Cbpo LiuInsiderSell1,968$124.32$244,661.76View SEC Filing  
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.12View SEC Filing  
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.52View SEC Filing  
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00View SEC Filing  
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.00View SEC Filing  
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60View SEC Filing  
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66View SEC Filing  
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78View SEC Filing  
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24View SEC Filing  
10/20/2015David GaoCEOSell258$105.00$27,090.00View SEC Filing  
10/19/2015David GaoCEOSell200$105.03$21,006.00View SEC Filing  
9/15/2015Ming YangCFOSell9,000$94.56$851,040.00View SEC Filing  
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.40View SEC Filing  
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.32View SEC Filing  
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.34View SEC Filing  
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for China Biologic Products (NASDAQ:CBPO)
Latest Headlines for China Biologic Products (NASDAQ:CBPO)
Source:
DateHeadline
finance.yahoo.com logoEdited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT
finance.yahoo.com - July 24 at 11:54 AM
americanbankingnews.com logo China Biologic Products, Inc. (CBPO) Receives Consensus Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - July 20 at 12:42 PM
finance.yahoo.com logoChina Biologic Products to Report Second Quarter of 2017 Financial Results
finance.yahoo.com - July 19 at 6:09 PM
finance.yahoo.com logoETFs with exposure to China Biologic Products, Inc. : July 17, 2017
finance.yahoo.com - July 17 at 5:20 PM
americanbankingnews.com logoChina Biologic Products, Inc. (NASDAQ:CBPO) Expected to Post Earnings of $1.36 Per Share
www.americanbankingnews.com - July 13 at 2:16 PM
finance.yahoo.com logoETFs with exposure to China Biologic Products, Inc. : July 6, 2017
finance.yahoo.com - July 6 at 6:14 PM
finance.yahoo.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : July 4, 2017
finance.yahoo.com - July 4 at 9:47 PM
americanbankingnews.com logoChina Biologic Products, Inc. (CBPO) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - July 4 at 7:44 PM
americanbankingnews.com logoChina Biologic Products, Inc. (NASDAQ:CBPO) Short Interest Down 31.7% in June
www.americanbankingnews.com - July 1 at 7:06 AM
nasdaq.com logoCBPO Makes Bullish Cross Above Critical Moving Average
www.nasdaq.com - June 30 at 10:05 PM
finance.yahoo.com logoETFs with exposure to China Biologic Products, Inc. : June 22, 2017
finance.yahoo.com - June 22 at 4:24 PM
americanbankingnews.com logo Analysts Expect China Biologic Products, Inc. (CBPO) Will Announce Earnings of $1.36 Per Share
www.americanbankingnews.com - June 19 at 2:08 PM
americanbankingnews.com logoZacks: China Biologic Products, Inc. (CBPO) Given Average Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - June 16 at 10:46 PM
finance.yahoo.com logoChina Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 4:55 PM
americanbankingnews.com logoChina Biologic Products, Inc. (CBPO) Stock Rating Reaffirmed by Jefferies Group LLC
www.americanbankingnews.com - June 12 at 8:28 AM
finance.yahoo.com logoChina Biologic Products, Inc. – Value Analysis (NASDAQ:CBPO) : June 9, 2017
finance.yahoo.com - June 9 at 4:45 PM
nasdaq.com logoChina Biologic Products Enters Oversold Territory (CBPO) - Nasdaq
www.nasdaq.com - June 8 at 10:11 PM
finance.yahoo.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : June 8, 2017
finance.yahoo.com - June 8 at 10:08 AM
americanbankingnews.com logo China Biologic Products Inc (CBPO) Receives Average Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - June 1 at 12:46 PM
americanbankingnews.com logoChina Biologic Products Inc (CBPO) Receives New Coverage from Analysts at Goldman Sachs Group Inc
www.americanbankingnews.com - May 30 at 6:58 PM
finance.yahoo.com logoChina Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders
finance.yahoo.com - May 19 at 9:06 PM
americanbankingnews.com logoChina Biologic Products Inc (CBPO) Short Interest Update
www.americanbankingnews.com - May 19 at 8:26 PM
americanbankingnews.com logoZacks: Analysts Set $135.67 Price Target for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - May 12 at 8:52 PM
nasdaq.com logoChina Biologic Products (CBPO) Shares Cross Below 200 DMA
www.nasdaq.com - May 11 at 4:48 PM
americanbankingnews.com logoChina Biologic Products Inc (CBPO) Insider Sells $873,675.00 in Stock
www.americanbankingnews.com - May 10 at 11:03 PM
seekingalpha.com logoChina Biologic Products' (CBPO) CEO David Gao on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 8 at 4:05 PM
americanbankingnews.com logoJefferies Group Comments on China Biologic Products Inc's FY2018 Earnings (CBPO)
www.americanbankingnews.com - May 8 at 11:58 AM
americanbankingnews.com logoZacks Investment Research Downgrades China Biologic Products Inc (CBPO) to Sell
www.americanbankingnews.com - May 5 at 7:38 PM
finance.yahoo.com logoThis Chinese Pharma Stock Has 20% Upside
finance.yahoo.com - May 5 at 2:20 AM
finance.yahoo.com logoEdited Transcript of CBPO earnings conference call or presentation 4-May-17 11:30am GMT
finance.yahoo.com - May 4 at 9:20 PM
finance.yahoo.com logoChina Biologic Products posts 1Q profit - Yahoo Finance
finance.yahoo.com - May 4 at 4:19 PM
finance.yahoo.com logoChina Biologic Products posts 1Q profit
finance.yahoo.com - May 4 at 4:19 PM
finance.yahoo.com logoInvestor Network: China Biologic Products, Inc. to Host Earnings Call
finance.yahoo.com - May 4 at 4:19 PM
finance.yahoo.com logoChina Biologic Reports Financial Results for the First Quarter of 2017 - Yahoo Finance
finance.yahoo.com - May 4 at 2:14 AM
reuters.com logoBRIEF-China Biologic reports Q1 earnings per share $1.06
www.reuters.com - May 3 at 9:13 PM
finance.yahoo.com logoChina Biologic Reports Financial Results for the First Quarter of 2017
finance.yahoo.com - May 3 at 9:13 PM
americanbankingnews.com logo$1.24 Earnings Per Share Expected for China Biologic Products Inc (CBPO) This Quarter
www.americanbankingnews.com - May 1 at 1:52 PM
americanbankingnews.com logoChina Biologic Products (CBPO) Receiving Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 10:54 AM
americanbankingnews.com logoChina Biologic Products (CBPO) Receives Media Impact Score of 0.17
www.americanbankingnews.com - April 25 at 3:58 PM
americanbankingnews.com logoBrokerages Expect China Biologic Products Inc (CBPO) to Announce $1.24 EPS
www.americanbankingnews.com - April 24 at 7:56 PM
americanbankingnews.com logoFavorable News Coverage Likely to Impact China Biologic Products (CBPO) Stock Price
www.americanbankingnews.com - April 22 at 12:53 PM
finance.yahoo.com logoChina Biologic Products to Report First Quarter of 2017 Financial Results
finance.yahoo.com - April 21 at 4:17 PM
nasdaq.com logoCBPO Crosses Above Key Moving Average Level
www.nasdaq.com - April 19 at 1:01 PM
americanbankingnews.com logoChina Biologic Products (CBPO) Earning Very Favorable News Coverage, Study Shows
www.americanbankingnews.com - April 18 at 9:26 AM
americanbankingnews.com logoChina Biologic Products (CBPO) Receiving Favorable News Coverage, Report Shows
www.americanbankingnews.com - April 15 at 10:29 AM
finance.yahoo.com logoChina Biologic Products, Inc. – Value Analysis (NASDAQ:CBPO) : April 12, 2017
finance.yahoo.com - April 12 at 4:09 PM
americanbankingnews.com logoZacks: Brokerages Expect China Biologic Products Inc (CBPO) Will Post Quarterly Sales of $0.00
www.americanbankingnews.com - April 12 at 12:37 PM
finance.yahoo.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : April 11, 2017
finance.yahoo.com - April 11 at 10:05 AM
finance.yahoo.com logoETFs with exposure to China Biologic Products, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 4:10 PM
americanbankingnews.com logoZacks: Brokerages Set $131.67 Price Target for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - April 6 at 8:45 PM

Social

Chart

China Biologic Products (CBPO) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff